Literature DB >> 31047903

Predicting individual treatment response in diabetes.

Hiddo J L Heerspink1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31047903     DOI： 10.1016/S2213-8587(19)30118-4

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  2 in total

1.  Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy.

Authors:  Youngsook Kim; Ji Hye Huh; Minyoung Lee; Eun Seok Kang; Bong-Soo Cha; Byung-Wan Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

2.  Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial.

Authors:  David C Wheeler; Niels Jongs; Bergur V Stefansson; Glenn M Chertow; Tom Greene; Fan Fan Hou; Anna Maria Langkilde; John J V McMurray; Peter Rossing; Michal Nowicki; István Wittmann; Ricardo Correa-Rotter; C David Sjöström; Robert D Toto; Hiddo J L Heerspink
Journal:  Nephrol Dial Transplant       Date:  2022-08-22       Impact factor: 7.186
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.